Home ›
Entities
› academia
› Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial
Research article (Neuro-Oncology, 2020) · cited 28× · AI/ML
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial
Summary
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial is a scholarly article[1].
Key Facts
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial. Retrieved May 24, 2026, from https://4ort.xyz/entity/value-of-dynamic-contrast-perfusion-mri-to-predict-early-response-to-bevacizumab-in-newly-diagnosed-glioblastoma-results
MLA“Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/value-of-dynamic-contrast-perfusion-mri-to-predict-early-response-to-bevacizumab-in-newly-diagnosed-glioblastoma-results.
BibTeX@misc{4ortxyz_value-of-dynamic-contrast-perfusion-mri-to-predict-early-response-to-bevacizumab-in-newly-diagnosed-glioblastoma-results_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial}}, year = {2026}, url = {https://4ort.xyz/entity/value-of-dynamic-contrast-perfusion-mri-to-predict-early-response-to-bevacizumab-in-newly-diagnosed-glioblastoma-results}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial — https://4ort.xyz/entity/value-of-dynamic-contrast-perfusion-mri-to-predict-early-response-to-bevacizumab-in-newly-diagnosed-glioblastoma-results (retrieved 2026-05-24)
